Extrahepatic Vitamin K-Dependent Gla-Proteins-Potential Cardiometabolic Biomarkers

Bistra Galunska1, Yoto Yotov2,3, Miglena Nikolova1

  • 1Department of Biochemistry Molecular Medicine and Nutrigenomics, Medical University of Varna, 9000 Varna, Bulgaria.

Insights

Vitamin K-dependent Gla-proteins inhibit vascular calcification. Inactive forms of matrix Gla-protein (MGP) and osteocalcin (OC) indicate calcification and cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Nutritional Science

Background:

  • Pathological vascular calcification (VC) is regulated by active inhibition.
  • Loss or inactivation of endogenous inhibitors, particularly vitamin K-dependent Gla-proteins, induces VC.
  • Extrahepatic vitamin K-dependent Gla-proteins (osteocalcin (OC), matrix Gla-protein (MGP), Gla-rich protein (GRP)) are crucial in cardiovascular pathology.

Purpose of the Study:

  • To review the role of extrahepatic vitamin K-dependent Gla-proteins in cardiovascular pathology.
  • To discuss the significance of different Gla-protein forms in VC pathogenesis.
  • To explore potential novel biomarkers for VC and cardiovascular events.

Main Methods:

  • Narrative review of existing literature.
  • Analysis of the functional roles of OC, MGP, and GRP in VC.
  • Evaluation of circulating Gla-protein forms as indicators of VC and cardiovascular risk.

Main Results:

  • Low non-phosphorylated MGP may indicate active calcification and serve as a VC biomarker.
  • High inactive MGP is linked to cardiovascular events, disease progression, mortality, and vitamin K deficiency.
  • The ucOC/cOC ratio reflects vitamin K status and arterial calcification; OC's role in global cardiovascular risk is unclear.
  • GRP mediates inflammation and calcification, potentially emerging as a key biomarker.

Conclusions:

  • Vitamin K-dependent Gla-proteins are vital inhibitors of VC.
  • Specific circulating forms of MGP, OC, and GRP show promise as biomarkers for VC and cardiovascular risk.
  • Dietary factors modifying Gla-proteins offer potential clinical benefits for managing VC.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
144
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K